drugset / Trial / NCT00587847
Campath Maintenance in Chronic Lymphocytic Leukemia
NaSingle-groupOpen-labelTreatment
Summary
This is a study designed to test whether giving campath (also known as alemtuzumab) on a maintenance schedule will prolong the time until the patient requires chemotherapy.
Timeline
- Start
- 2005-08
- Primary completion
- 2009-11
- Completion
- 2009-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alemtuzumab | Monoclonal antibody | 30 mg | Subcutaneous |